APPLICATIONS PUBLISHED 8 OCTOBER 2003
Published: 1-Mar-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Self-emulsifying lipid matrix (SELM)
F Hoffmann-La Roche 1349541*
Amoxycillin pellets
SmithKline Beecham 1349542*
Method for producing tablets from plant extracts
Steigerwald Arzneimittelwerk 1349543*
Adhesive label with fluidifying agents for natural airway secretions
Labtec Gesellschaft fur Technologische Forschung und Entwicklung 1349544*
Pharmaceutical compsns of fenretinide having increased bioavailability and methods of using the same
Children's Hospital of Los Angeles 1349545*
Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effects
Boehringer Ingelheim Pharma 1349546*
Use of 5-aminolevulinic acid for the prophylaxis of restenosis
Photonamic 1349547*
Methods and compsns for treating periodontal disease
Merck 1349548*
Novel medicament compsns based on anticholinesterase drugs and on ciclesonides
Boehringer Ingelheim Pharma 1349549*
Substituted 4-quinolones
The University of Nottingham 1349550*
A method for treating erectile dysfunction
Orion Corp 1349551*
Pyrazolo 3,4-D]pyrimidine derivatives and their use as purinergic receptor antagonists
Vernalis Research Ltd 1349552*
Dihyro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
Bsp Pharma 1349553*
Compsns and methods for treating an arthritic condition
Tufts University 1349554*
Treatment of cancer by reduction of intracellular energy and pyrimidines
Sloan-Kettering Institute for Cancer Research 1349555*
Activated charcoal based compsn and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
Innovation Ventures 1349556*
Fractions of snake blood, their preparation and use as therapeutic agents
Palmieri, Angelo Michele 1349557*
Compsn comprising Melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
Anglolab; Kim, Min-Young 1349558*
Compsn for inducing secretion of insulin-like growth factor-1
Naturalendo Tech 1349559*
Black tea extract for prevention of disease
Rutgers, The State University 1349560*
Local use of essential oils for treating herpes labialis
Walther Schoenenberger Pflanzensaftwerk; Weiss, Markus M; Tarabichi, Anwar 1349561*
Inhibiting GS-FDH to modulate NO bioactivity
Duke University, Office of Science and Technology 1349562*
Peptide YY and peptide YY agonists for treatment of metabolic disorders
Amylin Pharmaceuticals 1349563*
Regulation of cell proliferation and differentiation using topically applied peptides
Holick, Michael F 1349564*
Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
Holick, Michael F 1349565*
Methods for ameliorating childhood infections
Washington University 1349566*
Compsns containing gangliosides of use in the treatment of skin disorders
Children's Memorial Hospital 1349567*
Immunomodulatory constructs and their uses
Aukland University 1349568*
Intrinsically fluorescent, self-multimerising MHC fusion proteins and complexes thereof
Becton, Dickinson and Co 1349569*
Enterohaemorrhagic Escherichia coli vaccine
The University of Saskatchewan 1349570*
Rotavirus enterotoxin NSP4 and methods of using same
Baylor College of Medicine 1349571*
Manufacturing method of combined vaccine
LG Life-Sciences 1349572*
Collectins as adjuvants
Jensenius, Lens Christian; Sjoholm, Anders 1349573*
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
Merck Patent 1349574*
Compsns for stimulating CD45 and therapy suppressing microglial activation associated with Alzheimer's disease
University of South Florida 1349575*
Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type I according to the Gell and Coombs classification, and for the treatment and prevention of dermatological DI
Institut fur Medizintechnologie Magdeburg 1349576*
Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
Asilomar Pharmaceuticals 1349577*
Medicinal association of a biguanine (metformin) and arginine
Dospharma 1349578*
Improved solubility and dispersibility by exposure to O X?
Cosmed Group 1349579*
Process to improve stability of a pharmaceutical compsn
Novartis 1349580*
